Okeios
Okeios is a Japan-based health-tech company operating a blockchain-secured Personal Data Store (PDS) platform that enables individuals, municipalities, and medical institutions to manage and exchange health data via consent-based controls, anchored by patented BCN and AI technologies and distributed through CMIC Group and Irom Group channels.
- Company typePrivate
- Founded2020
- HeadquartersFukuoka, Japan
- Headcount—
- GTM typeB2B
- OfferingSoftware
What Okeios does
Okeios Co., Ltd. (株式会社オケイオス) is a Japan-based health-technology company headquartered in Fukuoka that operates a blockchain-secured information distribution platform built around a Personal Data Store (PDS) architecture. The platform allows individuals to register and manage their own health data — examination records, medical history, lifestyle logs — and to share that data on consent-based terms with municipalities, medical institutions, insurers, research institutions, and corporate health programs. Blockchain is used not for raw data storage but for storing digital certificates derived from source health data, providing authenticity, confidentiality, traceability, and identity verification. OKEIOS is an equity-method affiliate of CMIC Holdings via CMIC Solutions (since September 2022) and re-booted as the operating entity in April 2026 following a business succession of the healthcare business from CMIC Trust.
The product surface is a platform-plus-modules architecture: the core information distribution platform is delivered through consumer apps (Mirai Health Handbook, an all-in-one health management app co-developed with Hiroshima University and the Kanshin COI; Mother-Child Health Management), enterprise modules for medical institutions and municipalities (DocTip, aSBoEMR combining PHR and EMR, municipal data health planning support), the aSBo Cloud System blockchain clinical trial information platform deployed with Irom Group, and a Risk Prediction AI for preventive health guidance. Two granted patents anchor the technology: the BCN Data Utilization System and the AI Event Class Determination System. The technology stack integrates Google Fit for wearable data ingestion and exposes SDK and API access for third-party health apps, insurance systems, and municipal platforms to participate in the consent-managed data exchange.
Commercially, OKEIOS earns revenue through platform licensing and PDS management subscriptions to municipalities and medical institutions, SDK/API licensing and transaction-style fees on data exchange, custom application development and integration services, and quotation-based enterprise contracts rather than published pricing. Go-to-market combines direct enterprise sales to Japanese local governments and medical institutions with channel partnerships through CMIC Group (pharmaceutical and clinical trial reach), Irom Group (clinical trial site network), and academic co-development with Hiroshima University, Kurume University, Keio University, and Fukuoka University. Government-level validation comes from METI Information Processing Support Institution certification (2019), METI cross-industry collaboration certification (2020), listing in the Digital Agency's Digital Garden City Nation service catalog (2023), and the 2024 Japan Patent Attorneys Association IP Utilization Award Grand Prize.
Okeios firmographics
Firmographics- Name
- Okeios
- Legal name
- 株式会社オケイオス
- Website
- https://okeios.co.jp
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Short description
- Okeios is a Japan-based health-tech company operating a blockchain-secured Personal Data Store (PDS) platform that enables individuals, municipalities, and medical institutions to manage and exchange health data via consent-based controls, anchored by patented BCN and AI technologies and distributed through CMIC Group and Irom Group channels.
- Ownership category
- akta.pro rank
Okeios industry classification
Industry- Product category
- Healthcare Data Exchange Platform
- NAICS
- Software Publishers (5132), Custom Computer Programming Services (541511)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- Consent, Preference & Data Rights Management (incl. HIPAA/GDPR support) (HLACAIAG)
- akta.pro secondary industries
- Patient-Mediated Exchange & Personal Health Data Access (Blue Button, SMART on FHIR) (HLACABAN), eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB), De-identification, Tokenization & Privacy-Preserving Data Platforms (HLACAIAK)
Keywords
Where Okeios is headquartered
LocationHeadquarters
- HQ city
- Fukuoka
- HQ country
- Japan
- HQ region
- Asia
Offices1 record
Markets served
Okeios business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Platform Access and PDS Management Services: OKEIOS provides its blockchain-based information distribution platform and PDS (Personal Data Store) management services to municipalities, medical institutions, and corporations. Revenue is derived from platform licensing, customization, and ongoing service fees.
- Application/SDK Licensing and API Access: Existing service providers can integrate with OKEIOS's platform via SDK and API to enable information exchange through PDS. Operators in healthcare, insurance, local government, and research access the platform to provide value-added services to individuals.
- Custom Application Development and Integration: Customization of individual apps (healthcare, PHR), information sharing apps (medical institutions, municipalities), and communication management apps for enterprise and government clients.
- Data Exchange Facilitation and Consent Management: The platform facilitates consent-based data exchange between individuals and data consumers (businesses, medical institutions, researchers), providing information trust functions and data catalog services for cross-industry data exchange.
Go-to-market motion3 records
Distribution channels5 records
Marketing channels4 records
Okeios product offering
Product offeringCore offering
Okeios develops and operates a blockchain-based information distribution platform built on a Personal Data Store (PDS) architecture that enables individuals to register, manage, and consent to share their own health, examination, and lifestyle data with medical institutions, municipalities, researchers, and corporate health programs. On top of this platform, the company sells the Mirai Health Handbook all-in-one health management app, a Mother-Child Health Management mobile app, the aSBo Cloud System for clinical trial information integration, and supporting AI-driven health risk prediction services.
Product overview
Okeios operates as a platform-plus-modules architecture centered on an information distribution platform. The core platform provides PDS (Personal Data Store) infrastructure with blockchain technology for secure health data management. Connected products include the flagship Mirai Health Handbook (みらい健康手帳) all-in-one health management app developed with Hiroshima University, the Mother-Child Health Management app, and the aSBo Cloud System for clinical trial management. Additional applications like DocTip and aSBoEMR provide specialized healthcare functions, while the重症化リスク予測AI enables predictive health analytics. The platform supports integration via SDK/API for third-party services and integrates with Google Fit for health data synchronization.
Differentiator
Problem solved
Functional benefit
Brands
- みらい健康手帳 (Mirai Health Handbook): 国立大学法人広島大学と感性COIが監修する大学発all-in-one健康管理アプリ。個人データを管理するPDS(Personal Data Store)コンセプトの健康管理アプリケーション。
- 母子健康管理アプリ
- aSBo Cloud System
Products and services
- Information Distribution Platform (情報流通プラットフォーム) Core blockchain-based information distribution platform providing PDS (Personal Data Store) infrastructure that enables personal data management with data authenticity, confidentiality, and traceability. Provides three service types: personal apps (healthcare/PHR apps), information sharing apps (for medical institutions and local governments), and communication management apps. Targeted at municipalities, medical institutions, and enterprises handling personal health information.
- Mirai Health Handbook (みらい健康手帳) University-developed all-in-one health management app co-created with Hiroshima University and Kanshin COI. Enables individual health data management through PDS architecture, supports health promotion, telemedicine assistance, and R&D data collection, and integrates with multiple PHR services for unified data management. Targets individual consumers seeking consolidated personal health record management.
- Mother-Child Health Management App (母子健康管理アプリ) Mobile application for maternal and child health management available on AppStore and GooglePlay. Enables tracking of infant health checkup data and provides digital health record management for mothers and children, including Google Fit integration for synchronized step, sleep, and body measurement data. Targeted at mothers managing infant health records and municipalities digitizing maternal-child health programs.
- aSBo Cloud System Blockchain-based clinical trial information integrated management platform developed in partnership with Irom Group for pharmaceutical development. Provides secure, tamper-proof management of clinical trial data across medical institutions. Targeted at clinical trial operators, pharmaceutical companies, and SMO/CRO networks.
Quantifiable outcome
- Supported Kurume University, CMIC Solutions, and OKEIOS in signing a DX promotion partnership for healthcare data exchange across multiple industries and companies, addressing new data fragmentation challenges from MyNumber and PHR service proliferation.
- +3 more outcomes
Companies that use Okeios
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles3 records
Okeios technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability3 records
Feature6 records
Okeios partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core, minor and secondary.
- 学校法人久留米大学 (Kurume University)coreThree-party DX partnership (久留米大学, シミックソリューションズ, オケイオス) for building a healthcare data exchange infrastructure using blockchain-type information management and information trust functions. Kurume University contributes its regional healthcare expertise and medical institution network, focusing on sleep quality-based health status assessment for regional healthcare improvement and healthy life expectancy extension. This partnership specifically addresses new data fragmentation challenges from MyNumber and PHR service proliferation.
- シミックソリューションズ株式会社 (CMIC Solutions Co., Ltd.) — DX PartnershipcoreBeyond the capital relationship, CMIC Solutions, Kurume University, and OKEIOS signed a three-party DX promotion demonstration agreement for healthcare data exchange. CMIC contributes pharmaceutical development know-how, healthcare professional support, and connections between municipalities and medical institutions for sustainable business model development.
- 国立大学法人 広島大学 / 感性COI (Hiroshima University / Kanshin COI)coreCo-development partnership with Hiroshima University and its Kanshin COI (Center of Innovation) for the all-in-one health management app みらい健康手帳 (Mirai Health Handbook). Hiroshima University supervised the app development leveraging its medical and healthcare research capabilities. The app incorporates outcomes from AMED programs and the Hiroshima Sandbox (2018-2021). The partnership enables integration of Hiroshima University's research outputs directly into the consumer-facing PHR app.
- 株式会社アイロムグループ (Irom Group Co., Ltd.)coreIrom Group (Tokyo Stock Exchange First Section: 2372) adopted OKEIOS's aSBo Cloud System — a blockchain-based clinical trial information integration management platform — for deployment across its clinical trial sites nationwide from June 2021. OKEIOS provides the information distribution platform technology while Irom Group provides the clinical trial operational infrastructure and institutional network. This is OKEIOS's entry into the pharmaceutical development and clinical trial information management market.
- 学校法人 慶應義塾大学 (Keio University)minorListed as a major client/partner on the company website under major business partners. Nature of collaboration likely involves health data research or platform development cooperation, though specific details are not publicly disclosed.
- 学校法人 福岡大学 (Fukuoka University)minorListed as a major client/partner on the company website under major business partners. Nature of collaboration likely involves health data research or regional healthcare initiatives in the Fukuoka region.
- 株式会社 ソホビatee (So-Health-Bee Co., Ltd.)minorListed as a major client/partner on the company website under major business partners (五十音順). Nature of collaboration not publicly disclosed.
- 株式会社NTT DoCoMo / 株式会社DPPヘルスパートナーズ (NTT DoCoMo / DPP Health Partners) — Hiroshima SandboxsecondaryCollaboration partners in the Hiroshima Sandbox program (2018-2021) for building a blockchain-based healthcare information management platform for Hiroshima prefecture residents. NTT DoCoMo contributed mobile technology and telecommunications infrastructure; DPP Health Partners contributed healthcare and wellness program expertise. The program resulted in the みらい健幸 app and its successor みらい健康手帳.
Scale indicators4 records
Recent moves8 records
Expansion highlights5 records
Okeios competitors and assessment
Company assessmentBroad incumbents
- Philips HealthSuite: Enterprise-scale cloud platform for connected health devices, patient data, and clinical workflows with consent and identity management. Comparable enterprise/governance positioning and a benchmark for what scaled health data infrastructure looks like.
- M3 Inc. Japanese digital healthcare platform operating MR-kun, MDLinx, and clinician networks with growing consumer health data assets. Relevant as a broad incumbent competing for healthcare data exchange, clinical trial, and consumer PHR segments.
- NTT Data Japan: Major Japanese IT services provider with broad healthcare offerings including EMR, regional healthcare networks, and government health information systems. Okeios already partners with NTT DoCoMo in Hiroshima Sandbox, and NTT Data represents the type of large incumbent Okeios must displace in municipal procurement.
- Apple Health Records: Apple's patient-mediated health records service aggregating EMR data from participating hospitals on consumer iPhones. Comparable patient-mediated data access model and represents the de facto global PHR incumbent Okeios must interoperate with.
Regional players
- LINE Healthcare: LY Corporation's healthcare subsidiary offering online consultation, health management apps, and PHR services on the LINE platform in Japan. Comparable in targeting Japanese consumers and municipalities for health data and wellness programs.
- DeNA Healthcare: Japanese internet company's healthcare division operating consumer health apps and healthcare data services. Comparable Japan-domestic PHR/data positioning and an obvious competitor in municipal and corporate health programs.
Direct peers
- Patientory: Blockchain-based healthcare information exchange and PHR platform enabling secure patient-mediated data sharing between individuals, providers, and payers. Directly comparable product positioning and underlying blockchain-for-health-data thesis.
- Welby: Japan's leading PHR platform company, providing disease-management and health-data apps used by patients, providers, insurers, and pharmaceutical companies. Most direct Japanese PHR competitor to Okeios's Mirai Health Handbook and municipal PHR offerings.
- Solve.Care: Blockchain healthcare platform coordinating patients, providers, and payers with consent-based data exchange and care administration. Comparable in offering decentralized data sovereignty and cross-stakeholder information distribution.
- BurstIQ: US-based platform using blockchain and distributed ledger technology for secure health data exchange, consent management, and PDS-style individual data sovereignty. Closest functional analog to Okeios's blockchain + PDS architecture in the global market.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Okeios compliance and trust
Trust signalCompliance2 records
Okeios financial estimates
Financial estimateRevenue estimate
Valuation estimate
Okeios leadership team
Management profileNumber of profiles
Profiles1 record
Okeios funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Okeios M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Okeios
What does Okeios do?
Okeios develops and operates a blockchain-based information distribution platform built on a Personal Data Store (PDS) architecture that enables individuals to register, manage, and consent to share their own health, examination, and lifestyle data with medical institutions, municipalities, researchers, and corporate health programs. On top of this platform, the company sells the Mirai Health Handbook all-in-one health management app, a Mother-Child Health Management mobile app, the aSBo Cloud System for clinical trial information integration, and supporting AI-driven health risk prediction services.
Is Okeios a public or private company?
Okeios is a private company. It is classified as corporate owned and is currently operating.
When was Okeios founded?
Okeios was founded in 2020.
Where is Okeios based?
Okeios is headquartered in Fukuoka, Japan, in the Asia region.
How does Okeios make money?
Four revenue lines are on record. Platform Access and PDS Management Services are the primary driver. The others are application/SDK Licensing and API Access, custom Application Development and Integration and data Exchange Facilitation and Consent Management.
Who are Okeios's main competitors?
Broad incumbents on record are Philips HealthSuite, M3 Inc., NTT Data Japan and Apple Health Records. Regional players are LINE Healthcare and DeNA Healthcare. Direct peers are Patientory, Welby, Solve.Care and BurstIQ.
Does Okeios have an API?
Yes. Okeios provides SDK and API access for third-party service providers to enable information distribution through the PDS (Personal Data Store) on the platform. The platform allows third-party applications (personal health apps, medical institution sharing apps, communication management apps) to integrate with the PDS infrastructure. Developer documentation is at www.okeios.co.jp/wp/product.
What industry is Okeios in?
Okeios's product category is Healthcare Data Exchange Platform. Its primary akta.pro industry code is HLACAIAG, Consent, Preference & Data Rights Management (incl. HIPAA/GDPR support), with a secondary code of HLACABAN, Patient-Mediated Exchange & Personal Health Data Access (Blue Button, SMART on FHIR). Its NAICS code is 5132 and its SIC code is 7372.